# Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera Hemodialysis Population

> **NCT02832323** · NA · TERMINATED · sponsor: **University Hospital, Brest** · enrollment: 94 (actual)

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

- **BIOLOGICAL:** Reticera

## Key facts

- **NCT ID:** NCT02832323
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06-22
- **Primary completion:** 2021-06-20
- **Final completion:** 2021-06-30
- **Target enrollment:** 94 (ACTUAL)
- **Why stopped:** inclusion difficulties
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02832323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02832323, "Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera Hemodialysis Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02832323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*